EKS-MUM-00433
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-MUM-00433
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TK/PDGFR615.19.8E-185593950358
StatusReviewed
Ensembl ProteinENSMUSP00000000476
UniProt AccessionP26618; Q3TQ37; Q62046; Q7TSJ3; Q8C4N3;
Protein NamePlatelet-derived growth factor receptor alpha
Protein Synonyms/Alias PDGF-R-alpha; PDGFR-alpha; Alpha platelet-derived growth factor receptor; Alpha-type platelet-derived growth factor receptor; CD140 antigen-like family member A; Platelet-derived growth factor alpha receptor;
Gene NamePdgfra
Gene Synonyms/Alias Pdgfra;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSMUSG00000029231ENSMUSP00000127173ENSMUST00000168162
ENSMUSG00000029231ENSMUSP00000000476ENSMUST00000000476
OrganismMus musculus
Functional DescriptionTyrosine-protein kinase that acts as a cell-surfacereceptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor.
Protein Length1089
Protein Sequence
(FASTA)
MGTSHQVFLV LSCLLTGPGL ISCQLLLPSI LPNENEKIVQ LNSSFSLRCV GESEVSWQHP 60
MSEEDDPNVE IRSEENNSGL FVTVLEVVNA SAAHTGWYTC YYNHTQTDES EIEGRHIYIY 120
VPDPDMAFVP LGMTDSLVIV EEDDSAIIPC RTTDPETQVT LHNNGRLVPA SYDSRQGFNG 180
TFSVGPYICE ATVKGRTFKT SEFNVYALKA TSELNLEMDA RQTVYKAGET IVVTCAVFNN 240
EVVDLQWTYP GEVRNKGITM LEEIKLPSIK LVYTLTVPKA TVKDSGEYEC AARQATKEVK 300
EMKRVTISVH EKGFVEIEPT FGQLEAVNLH EVREFVVEVQ AYPTPRISWL KDNLTLIENL 360
TEITTDVQKS QETRYQSKLK LIRAKEEDSG HYTIIVQNED DVKSYTFELS TLVPASILDL 420
VDDHHGSGGG QTVRCTAEGT PLPEIDWMIC KHIKKCNNDT SWTVLASNVS NIITELPRRG 480
RSTVEGRVSF AKVEETIAVR CLAKNNLSVV ARELKLVAPT LRSELTVAAA VLVLLVIVIV 540
SLIVLVVIWK QKPRYEIRWR VIESISPDGH EYIYVDPMQL PYDSRWEFPR DGLVLGRILG 600
SGAFGKVVEG TAYGLSRSQP VMKVAVKMLK PTARSSEKQA LMSELKIMTH LGPHLNIVNL 660
LGACTKSGPI YIITEYCFYG DLVNYLHKNR DSFMSQHPEK PKKDLDIFGL NPADESTRSY 720
VILSFENNGD YMDMKQADTT QYVPMLERKE VSKYSDIQRS LYDRPASYKK KSMLDSEVKN 780
LLSDDDSEGL TLLDLLSFTY QVARGMEFLA SKNCVHRDLA ARNVLLAQGK IVKICDFGLA 840
RDIMHDSNYV SKGSTFLPVK WMAPESIFDN LYTTLSDVWS YGILLWEIFS LGGTPYPGMM 900
VDSTFYNKIK SGYRMAKPDH ATSEVYEIMV QCWNSEPEKR PSFYHLSEIV ENLLPGQYKK 960
SYEKIHLDFL KSDHPAVARM RVDSDNAYIG VTYKNEEDKL KDWEGGLDEQ RLSADSGYII 1020
PLPDIDPVPE EEDLGKRNRH SSQTSEESAI ETGSSSSTFI KREDETIEDI DMMDDIGIDS 1080
SDLVEDSFL 1089
Nucleotide Sequence
(FASTA)
ATGGGGACCT CCCACCAGGT CTTTCTGGTC CTCAGCTGTC TCCTCACAGG GCCGGGCCTC 60
ATCTCCTGCC AGCTCTTATT ACCCTCTATC CTCCCAAACG AGAATGAGAA GATTGTGCAG 120
CTGAATTCGT CCTTTTCTCT GAGATGCGTT GGGGAGAGTG AAGTGAGCTG GCAGCACCCC 180
ATGTCTGAAG AAGACGACCC CAACGTGGAA ATCAGAAGTG AGGAGAACAA CAGTGGCCTC 240
TTTGTCACAG TGCTGGAAGT GGTTAACGCC TCCGCAGCCC ACACCGGATG GTACACTTGC 300
TACTACAACC ACACTCAGAC GGATGAGAGT GAGATCGAAG GCAGGCACAT TTACATCTAT 360
GTACCAGACC CAGACATGGC CTTTGTGCCT CTCGGGATGA CCGATTCCTT AGTCATCGTG 420
GAAGAGGATG ACTCTGCCAT CATACCTTGC CGCACCACAG ATCCGGAGAC TCAAGTAACC 480
TTGCACAATA ACGGGAGGCT GGTGCCTGCC TCCTATGACA GCAGGCAGGG CTTCAACGGA 540
ACCTTCAGCG TGGGGCCTTA CATCTGTGAG GCCACCGTCA AAGGGAGGAC GTTCAAGACC 600
AGCGAGTTTA ATGTTTATGC CTTGAAAGCA ACGTCAGAAC TGAATCTGGA GATGGACGCA 660
CGCCAGACTG TGTATAAGGC AGGAGAAACG ATCGTGGTGA CCTGTGCCGT CTTTAACAAC 720
GAGGTCGTTG ACCTGCAGTG GACTTACCCT GGAGAAGTGA GAAACAAAGG TATCACCATG 780
CTGGAGGAGA TCAAACTCCC ATCCATCAAA CTGGTGTACA CTTTGACCGT CCCCAAGGCC 840
ACGGTGAAGG ACAGTGGAGA GTATGAATGT GCTGCCCGTC AGGCCACTAA AGAGGTCAAG 900
GAAATGAAGA GAGTCACCAT TTCTGTCCAC GAGAAAGGCT TCGTCGAGAT TGAGCCCACC 960
TTTGGCCAGC TGGAAGCTGT CAACTTGCAC GAAGTCAGAG AGTTCGTGGT GGAGGTGCAG 1020
GCCTACCCGA CGCCCAGGAT ATCGTGGCTG AAGGACAACT TGACTCTGAT AGAGAATCTC 1080
ACCGAGATCA CCACTGATGT ACAGAAGAGT CAGGAAACAA GGTATCAGAG CAAATTAAAG 1140
CTGATCCGGG CTAAGGAAGA AGACAGTGGC CATTACACCA TTATAGTTCA AAATGAGGAT 1200
GACGTGAAGA GTTACACGTT TGAGCTGTCA ACCCTAGTTC CTGCATCCAT TTTGGATCTC 1260
GTAGATGACC ACCATGGCTC TGGCGGGGGA CAGACTGTGA GGTGTACAGC CGAAGGCACC 1320
CCTCTTCCAG AAATCGACTG GATGATCTGC AAGCATATTA AGAAATGTAA TAATGACACT 1380
TCGTGGACAG TTTTGGCCAG CAATGTCTCA AATATTATCA CAGAGCTCCC TCGCCGTGGC 1440
AGGAGTACCG TGGAGGGACG AGTGTCCTTC GCCAAAGTGG AAGAGACCAT CGCAGTTCGA 1500
TGCCTGGCAA AGAACAACCT CAGCGTTGTG GCCCGTGAGC TGAAGCTGGT GGCTCCCACT 1560
CTGCGATCTG AACTCACAGT GGCGGCCGCA GTGTTGGTGC TGTTGGTGAT TGTCATTGTC 1620
TCTCTCATCG TCCTGGTGGT CATTTGGAAG CAGAAACCAC GGTATGAAAT TCGCTGGAGG 1680
GTTATCGAGT CAATCAGCCC CGATGGACAT GAGTATATCT ATGTGGACCC CATGCAGTTG 1740
CCTTACGACT CCAGATGGGA ATTCCCGAGA GATGGCCTCG TGCTTGGTCG GATTTTGGGA 1800
TCCGGTGCAT TTGGGAAAGT GGTCGAAGGT ACAGCTTATG GATTAAGCCG GTCCCAACCT 1860
GTAATGAAGG TGGCTGTGAA GATGCTCAAA CCCACAGCCA GGTCTAGTGA AAAGCAGGCT 1920
CTCATGTCTG AGCTGAAGAT AATGACTCAC CTGGGGCCAC ATTTGAACAT TGTGAACTTG 1980
CTGGGAGCCT GCACCAAGTC AGGTCCCATT TACATCATCA CAGAATACTG CTTCTATGGG 2040
GATTTGGTCA ACTACTTGCA TAAGAACAGA GATAGCTTCA TGAGCCAACA CCCAGAGAAG 2100
CCGAAGAAAG ACCTGGACAT CTTTGGATTG AATCCTGCAG ACGAGAGCAC AAGAAGTTAT 2160
GTGATTTTGT CTTTTGAAAA TAACGGCGAC TACATGGACA TGAAGCAAGC TGATACCACA 2220
CAGTATGTCC CCATGCTTGA AAGGAAAGAG GTTTCTAAAT ACTCTGACAT CCAGAGATCG 2280
CTGTACGATC GGCCAGCCTC CTACAAGAAG AAATCCATGC TAGACTCAGA AGTCAAAAAC 2340
CTCCTTTCGG ACGATGACTC CGAGGGTCTG ACTTTGCTGG ATCTATTGAG CTTCACCTAT 2400
CAAGTTGCTC GAGGAATGGA ATTTTTGGCT TCGAAAAATT GTGTCCACCG GGACCTGGCT 2460
GCCCGCAACG TCCTCCTGGC GCAAGGAAAA ATTGTGAAGA TCTGTGATTT TGGCCTGGCC 2520
AGAGACATCA TGCACGATTC CAACTACGTG TCAAAAGGCA GTACTTTCCT GCCTGTGAAG 2580
TGGATGGCAC CCGAGAGCAT CTTCGACAAC CTCTACACCA CGCTGAGTGA CGTCTGGTCC 2640
TATGGCATTC TGCTCTGGGA AATCTTTTCC CTTGGTGGCA CACCCTATCC TGGCATGATG 2700
GTCGATTCTA CTTTCTACAA TAAGATCAAG AGTGGATACC GGATGGCCAA ACCTGACCAT 2760
GCCACCAGTG AAGTCTATGA GATCATGGTG CAGTGCTGGA ACAGTGAGCC CGAGAAGAGA 2820
CCCTCCTTCT ACCACCTCAG CGAGATAGTG GAGAACCTGT TGCCGGGACA ATACAAGAAG 2880
AGTTATGAAA AGATTCACCT GGACTTCCTA AAGAGTGACC ATCCGGCCGT GGCACGCATG 2940
CGGGTGGACT CTGATAATGC GTACATCGGT GTCACTTACA AAAATGAAGA GGATAAGCTG 3000
AAGGACTGGG AAGGTGGCCT GGACGAACAG AGACTGAGCG CTGACAGTGG CTACATCATC 3060
CCCCTGCCAG ACATTGACCC TGTTCCAGAG GAGGAAGACC TGGGCAAGAG GAACAGACAC 3120
AGCTCACAGA CTTCGGAAGA GAGTGCCATC GAGACAGGTT CCAGTAGTTC CACCTTCATC 3180
AAGAGAGAGG ACGAGACCAT CGAGGACATC GACATGATGG ATGACATTGG TATAGATTCC 3240
TCGGACCTGG TGGAGGACAG CTTCCTGTAA 3270
Domain Profile
S: 1     lelGkvlGsGafGkvveatayGlsksdavlkvavkmlkstarssekealmselkilshlG  60
         l+lG++lGsGafGkvve+tayGls+s++v+kvavkmlk+tarssek+almselki++hlG
Q: 593   LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG  652
         78**********************************************************
S: 61    ehenivnllGactkgGpiyviteyccyGdllnylrrkresflkkslekkkekeeeldska  120
         +h+nivnllGactk+Gpiy+iteyc+yGdl+nyl+++r+sf++++ ek   ++++ld+++
Q: 653   PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFMSQHPEK---PKKDLDIFG  709
         *********************************************999...999******
S: 121   l.ladkslrsksslssesseeyvdlkkd................vsdvssskadklasek  163
         l +ad+s+rs+++ls+e++++y+d+k++                +sd+++s +d++as+k
Q: 710   LnPADESTRSYVILSFENNGDYMDMKQAdttqyvpmlerkevskYSDIQRSLYDRPASYK  769
         *9*************************9********************************
S: 164   kksalerevkaaleeedsevleledllsfsyqvakGmeflaskncvhrdlaarnvllteG  223
         kks+l++evk+ l+++dse+l+l dllsf+yqva+Gmeflaskncvhrdlaarnvll++G
Q: 770   KKSMLDSEVKNLLSDDDSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  829
         ************************************************************
S: 224   kvvkicdfGlardimkdsnyvvkGnarlpvkwmapesifdslytvksdvwsyGillweif  283
         k+vkicdfGlardim+dsnyv+kG+++lpvkwmapesifd+lyt+ sdvwsyGillweif
Q: 830   KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF  889
         ************************************************************
S: 284   slGstpypgllvdskfyklikeGyrmaqpayateeiyeimqkcweaepekrpsfkqlvel  343
         slG+tpypg++vds+fy++ik+Gyrma+p++at+e+yeim++cw++epekrpsf++l+e+
Q: 890   SLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVQCWNSEPEKRPSFYHLSEI  949
         *********************************************************998
S: 344   l  344
         +
Q: 950   V  950
         6
Domain Sequence
(FASTA)
LVLGRILGSG AFGKVVEGTA YGLSRSQPVM KVAVKMLKPT ARSSEKQALM SELKIMTHLG 60
PHLNIVNLLG ACTKSGPIYI ITEYCFYGDL VNYLHKNRDS FMSQHPEKPK KDLDIFGLNP 120
ADESTRSYVI LSFENNGDYM DMKQADTTQY VPMLERKEVS KYSDIQRSLY DRPASYKKKS 180
MLDSEVKNLL SDDDSEGLTL LDLLSFTYQV ARGMEFLASK NCVHRDLAAR NVLLAQGKIV 240
KICDFGLARD IMHDSNYVSK GSTFLPVKWM APESIFDNLY TTLSDVWSYG ILLWEIFSLG 300
GTPYPGMMVD STFYNKIKSG YRMAKPDHAT SEVYEIMVQC WNSEPEKRPS FYHLSEIV 358
KeywordAlternative splicing; ATP-binding; Cell membrane; Chemotaxis; Complete proteome; Developmental protein; Disulfide bond; Glycoprotein; Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding; Phosphoprotein; Proto-oncogene; Receptor; Reference proteome; Repeat; Signal; Transferase; Transmembrane; Transmembrane helix; Tyrosine-protein kinase; Ubl conjugation.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Bos taurus"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Equus caballus"; ?>Felis catus"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Homo sapiens"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Monodelphis domestica"; ?>Mustela putorius furo"; ?>Myotis lucifugus"; ?>Nomascus leucogenys"; ?>Ochotona princeps"; ?>Oreochromis niloticus"; ?>Ornithorhynchus anatinus"; ?>Oryctolagus cuniculus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Pongo abelii"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tetraodon nigroviridis"; ?>Tursiops truncatus"; ?>Xenopus tropicalis"; ?>
EKS-AIM-00373
EKS-ANC-00388
EKS-BOT-00401
EKS-CAJ-00405
EKS-CAF-00401
EKS-CAP-00430
EKS-EQC-00393
EKS-FEC-00385
EKS-GAG-00339
EKS-GAA-00490
EKS-GOG-00393
EKS-HOS-00407
EKS-ICT-00380
EKS-LAC-00417
EKS-LOA-00410
EKS-MAM-00400
EKS-MEG-00333
EKS-MOD-00390
EKS-MUP-00395
EKS-MYL-00396
EKS-NOL-00366
EKS-OCP-00085
EKS-ORN-00512
EKS-ORA-00350
EKS-ORC-00376
EKS-ORL-00470
EKS-OTG-00403
EKS-PAT-00380
EKS-PES-00356
EKS-POA-00392
EKS-RAN-00416
EKS-SAH-00370
EKS-TAG-00476
EKS-TAR-00508
EKS-TEN-00509
EKS-TUT-00117
EKS-XET-00512
Gene Ontology
GO:0005737; C:cytoplasm
GO:0009897; C:external side of plasma membrane
GO:0005887; C:integral to plasma membrane
GO:0005634; C:nucleus
GO:0005524; F:ATP binding
GO:0005018; F:platelet-derived growth factor alpha-receptor activity
GO:0048407; F:platelet-derived growth factor binding
GO:0042803; F:protein homodimerization activity
GO:0005021; F:vascular endothelial growth factor-activated receptor activity
GO:0030325; P:adrenal gland development
GO:0055003; P:cardiac myofibril assembly
GO:0060326; P:cell chemotaxis
GO:0071230; P:cellular response to amino acid stimulus
GO:0007204; P:elevation of cytosolic calcium ion concentration
GO:0048701; P:embryonic cranial skeleton morphogenesis
GO:0048557; P:embryonic digestive tract morphogenesis
GO:0008210; P:estrogen metabolic process
GO:0030198; P:extracellular matrix organization
GO:0060325; P:face morphogenesis
GO:0042063; P:gliogenesis
GO:0001701; P:in utero embryonic development
GO:0048839; P:inner ear development
GO:0033327; P:Leydig cell differentiation
GO:0030324; P:lung development
GO:0001553; P:luteinization
GO:0030539; P:male genitalia development
GO:0072277; P:metanephric glomerular capillary formation
GO:0010544; P:negative regulation of platelet activation
GO:0042475; P:odontogenesis of dentin-containing tooth
GO:0060021; P:palate development
GO:0018108; P:peptidyl-tyrosine phosphorylation
GO:0048015; P:phosphatidylinositol-mediated signaling
GO:0070527; P:platelet aggregation
GO:0030335; P:positive regulation of cell migration
GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway
GO:0045740; P:positive regulation of DNA replication
GO:0070374; P:positive regulation of ERK1 and ERK2 cascade
GO:0048146; P:positive regulation of fibroblast proliferation
GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity
GO:0010863; P:positive regulation of phospholipase C activity
GO:0046777; P:protein autophosphorylation
GO:0050920; P:regulation of chemotaxis
GO:2000739; P:regulation of mesenchymal stem cell differentiation
GO:0034097; P:response to cytokine stimulus
GO:0032355; P:response to estradiol stimulus
GO:0055093; P:response to hyperoxia
GO:0010035; P:response to inorganic substance
GO:0061298; P:retina vasculature development in camera-type eye
GO:0023019; P:signal transduction involved in regulation of gene expression
GO:0048010; P:vascular endothelial growth factor receptor signaling pathway
KEGG
mmu:18595;
InterPros
IPR007110; Ig-like.
IPR013783; Ig-like_fold.
IPR013098; Ig_I-set.
IPR003599; Ig_sub.
IPR003598; Ig_sub2.
IPR011009; Kinase-like_dom.
IPR000719; Prot_kinase_cat_dom.
IPR017441; Protein_kinase_ATP_BS.
IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
IPR008266; Tyr_kinase_AS.
IPR020635; Tyr_kinase_cat_dom.
IPR016243; Tyr_kinase_CSF1/PDGF_rcpt.
IPR001824; Tyr_kinase_rcpt_3_CS.
IPR009134; Tyr_kinase_VEGFR_rcpt_N.
Pfam
PF07679; I-set; 2.
PF07714; Pkinase_Tyr; 1.
SMARTs
SM00409; IG; 2.
SM00408; IGc2; 1.
SM00219; TyrKc; 1.
Prosites
PS50835; IG_LIKE; 3.
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS00240; RECEPTOR_TYR_KIN_III; 1.
Prints
PR01832; VEGFRECEPTOR.
Created Date20-Feb-2013